Category: Life Sciences
Global Life Sciences
-
Narcolepsy Therapeutics
... at a CAGR of 7.2% over the analysis period 2023-2030. Narcolepsy with Cataplexy Therapeutics, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.9 Billion by the ... Read More
-
mHealth (Mobile Health) Services
... reach US$237.6 Billion by 2030, growing at a CAGR of 27.9% over the analysis period 2023-2030. Mobile Monitoring Services, one of the segments analyzed in the report, is expected to record a 27.0% CAGR and ... Read More
-
High Temperature Insulation (HTI)
... reach US$9.2 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Ceramic Fibers, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach ... Read More
-
Medical Specialty Bags
... by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Ostomy Bags, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$2.7 Billion by ... Read More
-
Orthopedic Devices
... at a CAGR of 6.3% over the analysis period 2023-2030. Joint Reconstruction Devices, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$44.6 Billion by the end ... Read More
-
Medical X-Ray
... at a CAGR of 5.2% over the analysis period 2023-2030. Digital X-Ray, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$13.5 Billion by the end of ... Read More
-
EEG, EMG and Evoked Potential Devices
... the year 2023, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. Electroencephalograph Equipment, one of the segments analyzed in the report, is expected to ... Read More
-
Mammography Equipment
... at a CAGR of 6.9% over the analysis period 2023-2030. 2-D Digital Mammography Systems, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$2.1 Billion by the ... Read More
-
Patient Scales
... at a CAGR of 2.6% over the analysis period 2023-2030. Floor Scales, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$55.8 Million by the end of ... Read More
-
Electrophoresis Equipment and Supplies
... reach US$2.4 Billion by 2030, growing at a CAGR of 3.0% over the analysis period 2023-2030. Gel Electrophoresis Systems, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and ... Read More
-
Laboratory Glassware and Plasticware
... reach US$7.6 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030. Glass Pipettes and Pipette Tips, one of the segments analyzed in the report, is expected to record a 1.5% ... Read More
-
Microscopes
... of 5.0% over the analysis period 2023-2030. Optical Microscopes, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$3.9 Billion by the end of the analysis period. ... Read More
-
Antibacterial Drugs
... at a CAGR of 3.9% over the analysis period 2023-2030. ß-lactams Drug Class, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$35.4 Billion by the end ... Read More
-
Biosimilars
... of 20.1% over the analysis period 2023-2030. Recombinant Non-glycosylated Proteins, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$62.4 Billion by the end of the analysis ... Read More
-
Food Allergy and Intolerance Products
... is expected to reach US$53.9 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Lactose-Free Products, one of the segments analyzed in the report, is expected to record a 5.1% ... Read More
-
Overactive Bladder (OAB) Therapeutics
... reach US$1.5 Billion by 2030, growing at a CAGR of 2.8% over the analysis period 2023-2030. Anticholinergics Therapy, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach ... Read More
-
Bone and Joint Health Supplements
... is expected to reach US$22.0 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Joint Supplements, one of the segments analyzed in the report, is expected to record a 6.3% ... Read More
-
Testosterone Replacement Therapy (TRT)
... reach US$2.5 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. TRT Topicals, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach ... Read More
-
Irritable Bowel Syndrome (IBS) Therapeutics
... is expected to reach US$3.4 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. IBS-D Therapeutics, one of the segments analyzed in the report, is expected to record a 6.9% ... Read More
-
Next Generation Sequencers
... by 2030, growing at a CAGR of 17.4% over the analysis period 2023-2030. Next Generation Sequencers Consumables, one of the segments analyzed in the report, is expected to record a 17.2% CAGR and reach US$26.6 ... Read More
-
Needle-Free Drug Injection Systems
... reach US$29.9 Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2023-2030. Jet Injectors Technology, one of the segments analyzed in the report, is expected to record a 9.5% CAGR and ... Read More
-
Full Body Scanners
... by 2030, growing at a CAGR of 11.4% over the analysis period 2023-2030. Millimeter Technology, one of the segments analyzed in the report, is expected to record a 11.8% CAGR and reach US$609.0 Million by ... Read More
-
Surgical Incision Closures
... by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Tissue Sealants, Adhesives & Topical Hemostats, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and ... Read More
-
Ophthalmic Instrumentation
... at a CAGR of 4.6% over the analysis period 2023-2030. Ophthalmic Disposables, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$3.6 Billion by the end of ... Read More
-
Picture Archiving and Communication Systems (PACS)
... the year 2023, is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Mid End PACS, one of the segments analyzed in the report, is expected ... Read More
Research Assistance
